[The effect of propylthiouracil on function of phagocytic peripheral blood cells in persons with thyroid hyperfunction].

INTRODUCTION It is known that hyperthyroidism as well as thyrosuppressive therapy can influence the cells of immunological system. OBJECTIVE To examine the function of phagocyte cells in persons with hyperthyroidism and to examine if propylthiouracil (PTU) influences this function. METHOD The study included 15 patients with hyperthyroidism and 10 healthy persons. The parameters of phagocytic activity of mononuclear and polymorphonuclear leucocytes were tested by method of ingestion of particles of inactivated yeast labeled with neutral-red. RESULTS It was demonstrated that patients with hyperthyroidism, before the onset of therapy as well as 14 days after introduction of PTU, had decreased number of leucocytes (before PTU: 6.7 +/- 3.2 x 10(9)/l, after PTU: 6.1 +/- 2.0 x 10(9)/l and control: 8.0 +/- 1.6 x 10(9)/l; p=0.039), PMN leucocytes (before PTU: 3.9 +/- 2,4 x 10(9)/l, after PTU: 3.5 +/- 1.6 x 10(9)/l and control: 4.8 +/- 0.9 x 10(9)/l; p=0.037) and number of phagocyte PMN cells (before PTU: 0.9 +/- 0.9 x 10(9)/l, after PTU: 0.9 +/- 0.7 x 10(9)/l and control: 1.3 +/- 0.6 x 10(9)/l; p<0,05), but they had increased index of phagocytosis (before PTU: 2.0 +/- 0.2, after PTU: 1.9 +/- 0.2 and control: 1.7 +/- 0.2; p=0.029), while capacity of phagocytosis remained unchanged (before PTU: 1.9 +/- 1.7 x 10(9)/l, after PTU: 1.6 +/- 1.9 x 10(9)/l and control: 2.4 +/- 1.4 x 10(9)/l; p>0.05). The number of mononuclear leucocytes and parameters of phagocytic activity of mononuclear phagocytes in persons with hyperthyroidism did not change significantly in comparison with the control group. CONCLUSION Patients with hyperthyroidism had decreased number of leucocytes, PMN leucocytes and number of phagocyte PMN cells, and increased index of phagocytosis, while capacity of phagocytosis remained unchanged. The number and parameters of phagocytic activity of mononuclear leucocytes did not change. PTU therapy had no effect on the examined parameters.

[1]  A. Avenell,et al.  A systematic review of drug therapy for Graves' hyperthyroidism. , 2005, European journal of endocrinology.

[2]  Andrew A. Rooney,et al.  Developmental atrazine exposure suppresses immune function in male, but not female Sprague-Dawley rats. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  D. Cooper.  Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. , 2003, The Journal of clinical endocrinology and metabolism.

[4]  S. Skeie,et al.  Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. , 2002, European journal of endocrinology.

[5]  J. Fang,et al.  Propylthiouracil-induced acute interstitial nephritis with acute renal failure requiring haemodialysis: successful therapy with steroids. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  N. Kerkvliet,et al.  Effects of induced hypo- and hyperthyroidism on immune function and plasma biochemistry in mallards (Anas platyrhynchos). , 1997, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.

[7]  H. Schuppe,et al.  T cells ignore the parent drug propylthiouracil but are sensitized to a reactive metabolite generated in vivo. , 1996, Clinical immunology and immunopathology.

[8]  R. Curi,et al.  Effect of hypo‐ and hyperthyroidism on the function and metabolism of macrophages in rats , 1995, Cell biochemistry and function.

[9]  M. Kohno,et al.  Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure. , 1988, Biochemical pharmacology.

[10]  F. Kenny,et al.  Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. , 1970, The Journal of pediatrics.